Literature DB >> 6824514

Cytotoxicity of sera from patients with scleroderma. Effects on human endothelial cells and fibroblasts in culture.

S Cohen, A R Johnson, E Hurd.   

Abstract

Sera from patients with progressive systemic sclerosis were compared with sera from normal individuals and from patients with other connective tissue diseases for cytotoxic effects on cultured human cells. More than 40% of the sera from patients with active progressive systemic sclerosis were cytotoxic by several criteria for pulmonary arterial or umbilical venous endothelial cells, foreskin fibroblasts, and neuroblastoma cells. Cytotoxic sera caused morphologic changes, uptake of trypan blue dye, and a decrease in the incorporation of 3H-thymidine into DNA. In contrast, only 4 sera from normal individuals or patients with other rheumatic diseases affected cell morphology, staining, or uptake of 3H-thymidine. Partial characterization of the cytotoxic factor indicated that it is sensitive to proteolysis by trypsin. The molecular weight of the factor was estimated to be similar to that of albumin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824514     DOI: 10.1002/art.1780260208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  19 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  The effects of scleroderma sera on endothelial cell survival in vitro.

Authors:  T Etoh; A Igarashi; K Iozumi; Y Ishibashi; K Takehara
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Spontaneous transformation and immortalization of human endothelial cells.

Authors:  K Takahashi; Y Sawasaki; J Hata; K Mukai; T Goto
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

Review 4.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Mitogenic activities for skin fibroblasts in the sera from untreated scleroderma patients at the early stage.

Authors:  A Igarashi; K Takehara; Y Soma; K Kikuchi; Y Ishibashi
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Lymphocytotoxic autoantibodies in progressive systemic sclerosis.

Authors:  K Herrmann; J Schaller; U F Haustein; C Baldauf; S Kiessig
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 8.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

9.  Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins.

Authors:  D R Blake; P Winyard; D G Scott; S Brailsford; A Blann; J Lunec
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

10.  Cytotoxic effects of sera from patients with systemic scleroderma: comparison of three different in vitro methods.

Authors:  S Majewski; M Błaszczyk; S Jabłonska; L Rudnicka; M Waşik; A Skiendzielewska; B Makieła
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.